HEADER MEMBRANE PROTEIN 11-OCT-21 7SHS TITLE APO-CHRMINE IN MSP1E3D1 LIPID NANODISC COMPND MOL_ID: 1; COMPND 2 MOLECULE: CHRMINE; COMPND 3 CHAIN: A, B, C; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: RHODOMONAS LENS; SOURCE 3 ORGANISM_TAXID: 354590; SOURCE 4 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS CHANNELRHODOPSIN, ION CHANNEL, MEMBRANE PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR K.TUCKER,S.BROHAWN REVDAT 3 31-AUG-22 7SHS 1 JRNL REVDAT 2 06-JUL-22 7SHS 1 SOURCE REVDAT 1 01-DEC-21 7SHS 0 JRNL AUTH K.TUCKER,S.SRIDHARAN,H.ADESNIK,S.G.BROHAWN JRNL TITL CRYO-EM STRUCTURES OF THE CHANNELRHODOPSIN CHRMINE IN LIPID JRNL TITL 2 NANODISCS. JRNL REF NAT COMMUN V. 13 4842 2022 JRNL REFN ESSN 2041-1723 JRNL PMID 35977941 JRNL DOI 10.1038/S41467-022-32441-7 REMARK 2 REMARK 2 RESOLUTION. 4.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : CTFFIND, PHENIX, CRYOSPARC REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 4.100 REMARK 3 NUMBER OF PARTICLES : 41053 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 7SHS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-OCT-21. REMARK 100 THE DEPOSITION ID IS D_1000260295. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : CHRMINE TRIMER REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : 14.40 REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.50 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : TFS TALOS REMARK 245 DETECTOR TYPE : GATAN K3 (6K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : NULL REMARK 245 MAXIMUM DEFOCUS (NM) : NULL REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 5000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 200 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 AYA A 2 REMARK 465 GLU A 286 REMARK 465 ASP A 287 REMARK 465 GLU A 288 REMARK 465 PHE A 289 REMARK 465 GLN A 290 REMARK 465 LYS A 291 REMARK 465 LEU A 292 REMARK 465 GLU A 293 REMARK 465 LEU A 294 REMARK 465 ASP A 295 REMARK 465 MET A 296 REMARK 465 ARG A 297 REMARK 465 LEU A 298 REMARK 465 SER A 299 REMARK 465 SER A 300 REMARK 465 ASN A 301 REMARK 465 GLY A 302 REMARK 465 GLU A 303 REMARK 465 ARG A 304 REMARK 465 LEU A 305 REMARK 465 ARG A 306 REMARK 465 ARG A 307 REMARK 465 LEU A 308 REMARK 465 SER A 309 REMARK 465 LEU A 310 REMARK 465 ASN A 311 REMARK 465 SER A 312 REMARK 465 LEU A 313 REMARK 465 GLU A 314 REMARK 465 VAL A 315 REMARK 465 LEU A 316 REMARK 465 PHE A 317 REMARK 465 GLN A 318 REMARK 465 AYA B 2 REMARK 465 GLU B 286 REMARK 465 ASP B 287 REMARK 465 GLU B 288 REMARK 465 PHE B 289 REMARK 465 GLN B 290 REMARK 465 LYS B 291 REMARK 465 LEU B 292 REMARK 465 GLU B 293 REMARK 465 LEU B 294 REMARK 465 ASP B 295 REMARK 465 MET B 296 REMARK 465 ARG B 297 REMARK 465 LEU B 298 REMARK 465 SER B 299 REMARK 465 SER B 300 REMARK 465 ASN B 301 REMARK 465 GLY B 302 REMARK 465 GLU B 303 REMARK 465 ARG B 304 REMARK 465 LEU B 305 REMARK 465 ARG B 306 REMARK 465 ARG B 307 REMARK 465 LEU B 308 REMARK 465 SER B 309 REMARK 465 LEU B 310 REMARK 465 ASN B 311 REMARK 465 SER B 312 REMARK 465 LEU B 313 REMARK 465 GLU B 314 REMARK 465 VAL B 315 REMARK 465 LEU B 316 REMARK 465 PHE B 317 REMARK 465 GLN B 318 REMARK 465 AYA C 2 REMARK 465 GLU C 286 REMARK 465 ASP C 287 REMARK 465 GLU C 288 REMARK 465 PHE C 289 REMARK 465 GLN C 290 REMARK 465 LYS C 291 REMARK 465 LEU C 292 REMARK 465 GLU C 293 REMARK 465 LEU C 294 REMARK 465 ASP C 295 REMARK 465 MET C 296 REMARK 465 ARG C 297 REMARK 465 LEU C 298 REMARK 465 SER C 299 REMARK 465 SER C 300 REMARK 465 ASN C 301 REMARK 465 GLY C 302 REMARK 465 GLU C 303 REMARK 465 ARG C 304 REMARK 465 LEU C 305 REMARK 465 ARG C 306 REMARK 465 ARG C 307 REMARK 465 LEU C 308 REMARK 465 SER C 309 REMARK 465 LEU C 310 REMARK 465 ASN C 311 REMARK 465 SER C 312 REMARK 465 LEU C 313 REMARK 465 GLU C 314 REMARK 465 VAL C 315 REMARK 465 LEU C 316 REMARK 465 PHE C 317 REMARK 465 GLN C 318 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 53 52.47 -94.38 REMARK 500 TRP A 223 7.20 -69.76 REMARK 500 THR B 53 52.40 -94.37 REMARK 500 TRP B 223 7.26 -69.78 REMARK 500 THR C 53 52.52 -94.35 REMARK 500 TRP C 223 7.22 -69.76 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 7SFK RELATED DB: PDB REMARK 900 CHRMINE REMARK 900 RELATED ID: 7SFJ RELATED DB: PDB REMARK 900 CHRMINE REMARK 900 RELATED ID: EMD-25135 RELATED DB: EMDB REMARK 900 APO-CHRMINE IN MSP1E3D1 LIPID NANODISC DBREF 7SHS A 2 318 PDB 7SHS 7SHS 2 318 DBREF 7SHS B 2 318 PDB 7SHS 7SHS 2 318 DBREF 7SHS C 2 318 PDB 7SHS 7SHS 2 318 SEQRES 1 A 317 AYA HIS ALA PRO GLY THR ASP GLN MET PHE TYR VAL GLY SEQRES 2 A 317 THR MET ASP GLY TRP TYR LEU ASP THR LYS LEU ASN SER SEQRES 3 A 317 VAL ALA ILE GLY ALA HIS TRP SER CYS PHE ILE VAL LEU SEQRES 4 A 317 THR ILE THR THR PHE TYR LEU GLY TYR GLU SER TRP THR SEQRES 5 A 317 SER ARG GLY PRO SER LYS ARG THR SER PHE TYR ALA GLY SEQRES 6 A 317 TYR GLN GLU GLU GLN ASN LEU ALA LEU PHE VAL ASN PHE SEQRES 7 A 317 PHE ALA MET LEU SER TYR PHE GLY LYS ILE VAL ALA ASP SEQRES 8 A 317 THR LEU GLY HIS ASN PHE GLY ASP VAL GLY PRO PHE ILE SEQRES 9 A 317 ILE GLY PHE GLY ASN TYR ARG TYR ALA ASP TYR MET LEU SEQRES 10 A 317 THR CYS PRO MET LEU VAL TYR ASP LEU LEU TYR GLN LEU SEQRES 11 A 317 ARG ALA PRO TYR ARG VAL SER CYS SER ALA ILE ILE PHE SEQRES 12 A 317 ALA ILE LEU MET SER GLY VAL LEU ALA GLU PHE TYR ALA SEQRES 13 A 317 GLU GLY ASP PRO ARG LEU ARG ASN GLY ALA TYR ALA TRP SEQRES 14 A 317 TYR GLY PHE GLY CYS PHE TRP PHE ILE PHE ALA TYR SER SEQRES 15 A 317 ILE VAL MET SER ILE VAL ALA LYS GLN TYR SER ARG LEU SEQRES 16 A 317 ALA GLN LEU ALA GLN ASP THR GLY ALA GLU HIS SER LEU SEQRES 17 A 317 HIS VAL LEU LYS PHE ALA VAL PHE THR PHE SER MET LEU SEQRES 18 A 317 TRP ILE LEU PHE PRO LEU VAL TRP ALA ILE CYS PRO ARG SEQRES 19 A 317 GLY PHE GLY TRP ILE ASP ASP ASN TRP THR GLU VAL ALA SEQRES 20 A 317 HIS CYS VAL CYS ASP ILE VAL ALA LYS SER CYS TYR GLY SEQRES 21 A 317 PHE ALA LEU ALA ARG PHE ARG LYS THR TYR ASP GLU GLU SEQRES 22 A 317 LEU PHE ARG LEU LEU GLU GLN LEU GLY HIS ASP GLU ASP SEQRES 23 A 317 GLU PHE GLN LYS LEU GLU LEU ASP MET ARG LEU SER SER SEQRES 24 A 317 ASN GLY GLU ARG LEU ARG ARG LEU SER LEU ASN SER LEU SEQRES 25 A 317 GLU VAL LEU PHE GLN SEQRES 1 B 317 AYA HIS ALA PRO GLY THR ASP GLN MET PHE TYR VAL GLY SEQRES 2 B 317 THR MET ASP GLY TRP TYR LEU ASP THR LYS LEU ASN SER SEQRES 3 B 317 VAL ALA ILE GLY ALA HIS TRP SER CYS PHE ILE VAL LEU SEQRES 4 B 317 THR ILE THR THR PHE TYR LEU GLY TYR GLU SER TRP THR SEQRES 5 B 317 SER ARG GLY PRO SER LYS ARG THR SER PHE TYR ALA GLY SEQRES 6 B 317 TYR GLN GLU GLU GLN ASN LEU ALA LEU PHE VAL ASN PHE SEQRES 7 B 317 PHE ALA MET LEU SER TYR PHE GLY LYS ILE VAL ALA ASP SEQRES 8 B 317 THR LEU GLY HIS ASN PHE GLY ASP VAL GLY PRO PHE ILE SEQRES 9 B 317 ILE GLY PHE GLY ASN TYR ARG TYR ALA ASP TYR MET LEU SEQRES 10 B 317 THR CYS PRO MET LEU VAL TYR ASP LEU LEU TYR GLN LEU SEQRES 11 B 317 ARG ALA PRO TYR ARG VAL SER CYS SER ALA ILE ILE PHE SEQRES 12 B 317 ALA ILE LEU MET SER GLY VAL LEU ALA GLU PHE TYR ALA SEQRES 13 B 317 GLU GLY ASP PRO ARG LEU ARG ASN GLY ALA TYR ALA TRP SEQRES 14 B 317 TYR GLY PHE GLY CYS PHE TRP PHE ILE PHE ALA TYR SER SEQRES 15 B 317 ILE VAL MET SER ILE VAL ALA LYS GLN TYR SER ARG LEU SEQRES 16 B 317 ALA GLN LEU ALA GLN ASP THR GLY ALA GLU HIS SER LEU SEQRES 17 B 317 HIS VAL LEU LYS PHE ALA VAL PHE THR PHE SER MET LEU SEQRES 18 B 317 TRP ILE LEU PHE PRO LEU VAL TRP ALA ILE CYS PRO ARG SEQRES 19 B 317 GLY PHE GLY TRP ILE ASP ASP ASN TRP THR GLU VAL ALA SEQRES 20 B 317 HIS CYS VAL CYS ASP ILE VAL ALA LYS SER CYS TYR GLY SEQRES 21 B 317 PHE ALA LEU ALA ARG PHE ARG LYS THR TYR ASP GLU GLU SEQRES 22 B 317 LEU PHE ARG LEU LEU GLU GLN LEU GLY HIS ASP GLU ASP SEQRES 23 B 317 GLU PHE GLN LYS LEU GLU LEU ASP MET ARG LEU SER SER SEQRES 24 B 317 ASN GLY GLU ARG LEU ARG ARG LEU SER LEU ASN SER LEU SEQRES 25 B 317 GLU VAL LEU PHE GLN SEQRES 1 C 317 AYA HIS ALA PRO GLY THR ASP GLN MET PHE TYR VAL GLY SEQRES 2 C 317 THR MET ASP GLY TRP TYR LEU ASP THR LYS LEU ASN SER SEQRES 3 C 317 VAL ALA ILE GLY ALA HIS TRP SER CYS PHE ILE VAL LEU SEQRES 4 C 317 THR ILE THR THR PHE TYR LEU GLY TYR GLU SER TRP THR SEQRES 5 C 317 SER ARG GLY PRO SER LYS ARG THR SER PHE TYR ALA GLY SEQRES 6 C 317 TYR GLN GLU GLU GLN ASN LEU ALA LEU PHE VAL ASN PHE SEQRES 7 C 317 PHE ALA MET LEU SER TYR PHE GLY LYS ILE VAL ALA ASP SEQRES 8 C 317 THR LEU GLY HIS ASN PHE GLY ASP VAL GLY PRO PHE ILE SEQRES 9 C 317 ILE GLY PHE GLY ASN TYR ARG TYR ALA ASP TYR MET LEU SEQRES 10 C 317 THR CYS PRO MET LEU VAL TYR ASP LEU LEU TYR GLN LEU SEQRES 11 C 317 ARG ALA PRO TYR ARG VAL SER CYS SER ALA ILE ILE PHE SEQRES 12 C 317 ALA ILE LEU MET SER GLY VAL LEU ALA GLU PHE TYR ALA SEQRES 13 C 317 GLU GLY ASP PRO ARG LEU ARG ASN GLY ALA TYR ALA TRP SEQRES 14 C 317 TYR GLY PHE GLY CYS PHE TRP PHE ILE PHE ALA TYR SER SEQRES 15 C 317 ILE VAL MET SER ILE VAL ALA LYS GLN TYR SER ARG LEU SEQRES 16 C 317 ALA GLN LEU ALA GLN ASP THR GLY ALA GLU HIS SER LEU SEQRES 17 C 317 HIS VAL LEU LYS PHE ALA VAL PHE THR PHE SER MET LEU SEQRES 18 C 317 TRP ILE LEU PHE PRO LEU VAL TRP ALA ILE CYS PRO ARG SEQRES 19 C 317 GLY PHE GLY TRP ILE ASP ASP ASN TRP THR GLU VAL ALA SEQRES 20 C 317 HIS CYS VAL CYS ASP ILE VAL ALA LYS SER CYS TYR GLY SEQRES 21 C 317 PHE ALA LEU ALA ARG PHE ARG LYS THR TYR ASP GLU GLU SEQRES 22 C 317 LEU PHE ARG LEU LEU GLU GLN LEU GLY HIS ASP GLU ASP SEQRES 23 C 317 GLU PHE GLN LYS LEU GLU LEU ASP MET ARG LEU SER SER SEQRES 24 C 317 ASN GLY GLU ARG LEU ARG ARG LEU SER LEU ASN SER LEU SEQRES 25 C 317 GLU VAL LEU PHE GLN HELIX 1 AA1 THR A 15 TYR A 20 1 6 HELIX 2 AA2 ASN A 26 THR A 53 1 28 HELIX 3 AA3 PHE A 63 GLN A 68 1 6 HELIX 4 AA4 GLU A 69 GLN A 71 5 3 HELIX 5 AA5 ASN A 72 GLY A 95 1 24 HELIX 6 AA6 TYR A 113 MET A 117 5 5 HELIX 7 AA7 THR A 119 LEU A 131 1 13 HELIX 8 AA8 TYR A 135 GLY A 159 1 25 HELIX 9 AA9 ASP A 160 LEU A 163 5 4 HELIX 10 AB1 ARG A 164 LEU A 199 1 36 HELIX 11 AB2 ALA A 205 LEU A 222 1 18 HELIX 12 AB3 ILE A 224 CYS A 233 1 10 HELIX 13 AB4 TRP A 244 LYS A 269 1 26 HELIX 14 AB5 ASP A 272 GLY A 283 1 12 HELIX 15 AB6 THR B 15 TYR B 20 1 6 HELIX 16 AB7 ASN B 26 THR B 53 1 28 HELIX 17 AB8 PHE B 63 GLN B 68 1 6 HELIX 18 AB9 GLU B 69 GLN B 71 5 3 HELIX 19 AC1 ASN B 72 GLY B 95 1 24 HELIX 20 AC2 TYR B 113 MET B 117 5 5 HELIX 21 AC3 THR B 119 LEU B 131 1 13 HELIX 22 AC4 TYR B 135 GLY B 159 1 25 HELIX 23 AC5 ASP B 160 LEU B 163 5 4 HELIX 24 AC6 ARG B 164 LEU B 199 1 36 HELIX 25 AC7 ALA B 205 LEU B 222 1 18 HELIX 26 AC8 ILE B 224 CYS B 233 1 10 HELIX 27 AC9 TRP B 244 LYS B 269 1 26 HELIX 28 AD1 ASP B 272 GLY B 283 1 12 HELIX 29 AD2 THR C 15 TYR C 20 1 6 HELIX 30 AD3 ASN C 26 THR C 53 1 28 HELIX 31 AD4 PHE C 63 GLN C 68 1 6 HELIX 32 AD5 GLU C 69 GLN C 71 5 3 HELIX 33 AD6 ASN C 72 GLY C 95 1 24 HELIX 34 AD7 TYR C 113 MET C 117 5 5 HELIX 35 AD8 THR C 119 LEU C 131 1 13 HELIX 36 AD9 TYR C 135 GLY C 159 1 25 HELIX 37 AE1 ASP C 160 LEU C 163 5 4 HELIX 38 AE2 ARG C 164 LEU C 199 1 36 HELIX 39 AE3 ALA C 205 LEU C 222 1 18 HELIX 40 AE4 ILE C 224 CYS C 233 1 10 HELIX 41 AE5 TRP C 244 LYS C 269 1 26 HELIX 42 AE6 ASP C 272 GLY C 283 1 12 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MTRIX1 1 0.999631 0.006681 0.026337 -3.97688 1 MTRIX2 1 0.026132 -0.501890 -0.864536 287.59355 1 MTRIX3 1 0.007442 0.864905 -0.501880 76.23616 1 MTRIX1 2 0.999466 0.032517 0.003269 -4.43986 1 MTRIX2 2 0.013117 -0.490763 0.871194 75.34627 1 MTRIX3 2 0.029933 -0.870686 -0.490928 285.74992 1